Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor (Q57692156)

6

object named as

Etienne Pays

0 references

author name string

Toya Nath Baral

1

0 references

Stefan Magez

2

0 references

Benoît Stijlemans

3

0 references

Katja Conrath

4

0 references

Serge Muyldermans

7

0 references

Patrick De Baetselier

https://scigraph.springernature.com/pub.10.1038/nm1395

8

0 references

language of work or name

English

0 references

publication date

9 April 2006

0 references

published in

Nature Medicine

0 references

volume

12

0 references

page(s)

580-584

0 references

issue

5

0 references

exact match

0 references

cites work

Apolipoprotein L-I is the trypanosome lytic factor of human serum

1 reference

7 January 2021

A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense

1 reference

7 January 2021

Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm

1 reference

7 January 2021

Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda.

1 reference

7 January 2021

1 reference

7 January 2021

Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene

1 reference

7 January 2021

Sleeping sickness: a tale of two diseases.

1 reference

7 January 2021

Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries

1 reference

7 January 2021

The molecular control of antigenic variation in Trypanosoma brucei

1 reference

7 January 2021

Treatment of human African trypanosomiasis--present situation and needs for research and development

1 reference

7 January 2021

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

1 reference

7 January 2021

The treatment of human African trypanosomiasis

1 reference

7 January 2021

Resistance to clinical drugs in African trypanosomes.

1 reference

7 January 2021

The trypanosome lytic factor of human serum and the molecular basis of sleeping sickness

1 reference

7 January 2021

The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein.

1 reference

7 January 2021

Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L

1 reference

7 January 2021

Functional heavy-chain antibodies in Camelidae

1 reference

7 January 2021

Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs

1 reference

7 January 2021

The glycoforms of a Trypanosoma brucei variant surface glycoprotein and molecular modeling of a glycosylated surface coat

1 reference

7 January 2021

Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes

1 reference

7 January 2021

Efficient cancer therapy with a nanobody-based conjugate

1 reference

7 January 2021

P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis

1 reference

7 January 2021

TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection

1 reference

7 January 2021

Efficient tumor targeting by single-domain antibody fragments of camels

1 reference

7 January 2021

Antigen Binding and Solubility Effects upon the Veneering of a Camel VHH in Framework-2 to Mimic a VH

1 reference

7 January 2021